Related references
Note: Only part of the references are listed.
Article
Medicine, General & Internal
Risks and benefits of phase 1 oncology trials, 1991 through 2002
E Horstmann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Article
Medicine, General & Internal
Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia.
BJ Druker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Article
Ethics
Phase I cancer trials -: A collusion of misunderstanding
M Miller
HASTINGS CENTER REPORT (2000)
Share Paper
